Search

Your search keyword '"Lindegaard, Jacob C."' showing total 20 results
Start Over Author "Lindegaard, Jacob C." Search Limiters Full Text
20 results on '"Lindegaard, Jacob C."'

4. Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort

Author

Nomden, Christel N., Pötter, Richard, de Leeuw, Astrid A.C., Tanderup, Kari, Lindegaard, Jacob C., Schmid, Maximilian P., Fortin, Israël, Haie-Meder, Christine, Mahantshetty, Umesh, Hoskin, Peter, Segedin, Barbara, Bruheim, Kjersti, Rai, Bhavana, Huang, Fleur, Cooper, Rachel, Van Der Steen Banasik, Elzbieta, Van Limbergen, Erik, and Jürgenliemk-Schulz, Ina M.

Published
2019
Full Text
View/download PDF

5. Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study

Author

Smet, Stéphanie, Pötter, Richard, Haie-Meder, Christine, Lindegaard, Jacob C., Schulz-Juergenliemk, Ina, Mahantshetty, Umesh, Segedin, Barbara, Bruheim, Kjersti, Hoskin, Peter, Rai, Bhavana, Huang, Fleur, Cooper, Rachel, van Limbergen, Erik, Tanderup, Kari, and Kirchheiner, Kathrin

Published
2018
Full Text
View/download PDF

6. Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study

Author

Najjari Jamal, Dina, Pötter, Richard, Haie-Meder, Christine, Lindegaard, Jacob C., Juergenliemk-Schulz, Ina Maria, Mahantshetty, Umesh, Segedin, Barbara, Bruheim, Kjersti, Hoskin, Peter, Rai, Bhavana, Wiebe, Ericka, Cooper, Rachel, Tanderup, Kari, and Kirchheiner, Kathrin

Published
2018
Full Text
View/download PDF

8. Dose–volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study

Author

Mazeron, Renaud, Fokdal, Lars U., Kirchheiner, Kathrin, Georg, Petra, Jastaniyah, Noha, Šegedin, Barbara, Mahantshetty, Umesh, Hoskin, Peter, Jürgenliemk-Schulz, Ina, Kirisits, Christian, Lindegaard, Jacob C., Dörr, Wolfgang, Haie-Meder, Christine, Tanderup, Kari, and Pötter, Richard

Published
2016
Full Text
View/download PDF

10. Dose–effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study

Author

Kirchheiner, Kathrin, Nout, Remi A., Lindegaard, Jacob C., Haie-Meder, Christine, Mahantshetty, Umesh, Segedin, Barbara, Jürgenliemk-Schulz, Ina M., Hoskin, Peter J., Rai, Bhavana, Dörr, Wolfgang, Kirisits, Christian, Bentzen, Søren M., Pötter, Richard, and Tanderup, Kari

Published
2016
Full Text
View/download PDF

11. Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study

Author

MS Radiotherapie, Cancer, Klinische Fysica RT, Westerveld, Henrike, Kirchheiner, Kathrin, Nout, Remi A., Tanderup, Kari, Lindegaard, Jacob C., Spampinato, Sofia, Sturdza, Alina, Nesvacil, Nicole, Bruheim, Kjersti, Hellebust, Taran P., Pieters, Bradley R., Kirisits, Christian, Jürgenliemk-Schulz, Ina M., Pötter, Richard, de Leeuw, Astrid A.C., MS Radiotherapie, Cancer, Klinische Fysica RT, Westerveld, Henrike, Kirchheiner, Kathrin, Nout, Remi A., Tanderup, Kari, Lindegaard, Jacob C., Spampinato, Sofia, Sturdza, Alina, Nesvacil, Nicole, Bruheim, Kjersti, Hellebust, Taran P., Pieters, Bradley R., Kirisits, Christian, Jürgenliemk-Schulz, Ina M., Pötter, Richard, and de Leeuw, Astrid A.C.

Published
2022

12. Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future

Author

MS Radiotherapie, Cancer, Spampinato, Sofia, Jensen, Nina B.K., Pötter, Richard, Fokdal, Lars U., Chargari, Cyrus, Lindegaard, Jacob C., Schmid, Maximilian P., Sturdza, Alina, Jürgenliemk-Schulz, Ina M., Mahantshetty, Umesh, Hoskin, Peter, Segedin, Barbara, Rai, Bhavana, Bruheim, Kjersti, Wiebe, Ericka, Van der Steen-Banasik, Elzbieta, Cooper, Rachel, Van Limbergen, Erik, Sundset, Marit, Pieters, Bradley R., Lutgens, Ludy C.H.W., Tan, Li Tee, Villafranca, Elena, Smet, Stéphanie, Jastaniyah, Noha, Nout, Remi A., Kirisits, Christian, Chopra, Supriya, Kirchheiner, Kathrin, Tanderup, Kari, EMBRACE Collaborative Group, Collaborative Group, MS Radiotherapie, Cancer, Spampinato, Sofia, Jensen, Nina B.K., Pötter, Richard, Fokdal, Lars U., Chargari, Cyrus, Lindegaard, Jacob C., Schmid, Maximilian P., Sturdza, Alina, Jürgenliemk-Schulz, Ina M., Mahantshetty, Umesh, Hoskin, Peter, Segedin, Barbara, Rai, Bhavana, Bruheim, Kjersti, Wiebe, Ericka, Van der Steen-Banasik, Elzbieta, Cooper, Rachel, Van Limbergen, Erik, Sundset, Marit, Pieters, Bradley R., Lutgens, Ludy C.H.W., Tan, Li Tee, Villafranca, Elena, Smet, Stéphanie, Jastaniyah, Noha, Nout, Remi A., Kirisits, Christian, Chopra, Supriya, Kirchheiner, Kathrin, Tanderup, Kari, and EMBRACE Collaborative Group, Collaborative Group

Published
2022

14. Image-guided adaptive brachytherapy (Igabt) for primary vaginal cancer:Results of the international multicenter retroembrave cohort study

Author

Westerveld, Henrike, Schmid, Maximilian P., Nout, Remi A., Chargari, Cyrus, Pieters, Bradley R., Creutzberg, Carien L., Sturdza, Alina, Lindegaard, Jacob C., van Kesteren, Zdenko, Mazeron, Renaud, Nesvacil, Nicole, Fokdal, Lars U., Westerveld, Henrike, Schmid, Maximilian P., Nout, Remi A., Chargari, Cyrus, Pieters, Bradley R., Creutzberg, Carien L., Sturdza, Alina, Lindegaard, Jacob C., van Kesteren, Zdenko, Mazeron, Renaud, Nesvacil, Nicole, and Fokdal, Lars U.

Published
2021

15. Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis

Author

MS Radiotherapie, Cancer, Spampinato, Sofia, Fokdal, Lars U., Pötter, Richard, Haie-Meder, Christine, Lindegaard, Jacob C., Schmid, Maximilian P., Sturdza, Alina, Jürgenliemk-Schulz, Ina M., Mahantshetty, Umesh, Segedin, Barbara, Bruheim, Kjersti, Hoskin, Peter, Rai, Bhavana, Huang, Fleur, Cooper, Rachel, van der Steen-Banasik, Elzbieta, Van Limbergen, Erik, Sundset, Marit, Westerveld, Henrike, Nout, Remi A., Jensen, Nina B.K., Kirisits, Christian, Kirchheiner, Kathrin, Tanderup, Kari, MS Radiotherapie, Cancer, Spampinato, Sofia, Fokdal, Lars U., Pötter, Richard, Haie-Meder, Christine, Lindegaard, Jacob C., Schmid, Maximilian P., Sturdza, Alina, Jürgenliemk-Schulz, Ina M., Mahantshetty, Umesh, Segedin, Barbara, Bruheim, Kjersti, Hoskin, Peter, Rai, Bhavana, Huang, Fleur, Cooper, Rachel, van der Steen-Banasik, Elzbieta, Van Limbergen, Erik, Sundset, Marit, Westerveld, Henrike, Nout, Remi A., Jensen, Nina B.K., Kirisits, Christian, Kirchheiner, Kathrin, and Tanderup, Kari

Published
2021

16. Results of image guided brachytherapy for stage IB cervical cancer in the RetroEMBRACE study

Author

MS Radiotherapie, Cancer, Petric, Primoz, Lindegaard, Jacob C., Sturdza, Alina, Fokdal, Lars, Kirchheiner, Kathrin, Tan, Li T., Schmid, Maximilian P., Haie-Meder, Christine, Jürgenliemk-Schulz, Ina M., van Limbergen, Erik, Hoskin, Peter, Gillham, Charles, Tharavichitkul, Ekkasit, Mahantshetty, Umesh, Villafranca, Elena, Tanderup, Kari, Kirisits, Christian, Pötter, Richard, MS Radiotherapie, Cancer, Petric, Primoz, Lindegaard, Jacob C., Sturdza, Alina, Fokdal, Lars, Kirchheiner, Kathrin, Tan, Li T., Schmid, Maximilian P., Haie-Meder, Christine, Jürgenliemk-Schulz, Ina M., van Limbergen, Erik, Hoskin, Peter, Gillham, Charles, Tharavichitkul, Ekkasit, Mahantshetty, Umesh, Villafranca, Elena, Tanderup, Kari, Kirisits, Christian, and Pötter, Richard

Published
2021

17. Response to Yuce Sari et al.

Author

MS Radiotherapie, Cancer, Spampinato, Sofia, Fokdal, Lars U., Pötter, Richard, Haie-Meder, Christine, Lindegaard, Jacob C., Schmid, Maximilian P., Sturdza, Alina, Jürgenliemk-Schulz, Ina M., Mahantshetty, Umesh, Segedin, Barbara, Bruheim, Kjersti, Hoskin, Peter, Rai, Bhavana, Huang, Fleur, Cooper, Rachel, van der Steen-Banasik, Elzbieta, Van Limbergen, Erik, Sundset, Marit, Westerveld, Henrike, Nout, Remi A., Jensen, Nina B.K., Kirisits, Christian, Kirchheiner, Kathrin, Tanderup, Kari, MS Radiotherapie, Cancer, Spampinato, Sofia, Fokdal, Lars U., Pötter, Richard, Haie-Meder, Christine, Lindegaard, Jacob C., Schmid, Maximilian P., Sturdza, Alina, Jürgenliemk-Schulz, Ina M., Mahantshetty, Umesh, Segedin, Barbara, Bruheim, Kjersti, Hoskin, Peter, Rai, Bhavana, Huang, Fleur, Cooper, Rachel, van der Steen-Banasik, Elzbieta, Van Limbergen, Erik, Sundset, Marit, Westerveld, Henrike, Nout, Remi A., Jensen, Nina B.K., Kirisits, Christian, Kirchheiner, Kathrin, and Tanderup, Kari

Published
2021

20. Image-Guided Adaptive Brachytherapy (IGABT) for Primary Vaginal Cancer: Results of the International Multicenter RetroEMBRAVE Cohort Study.

Author

Westerveld, Henrike, Schmid, Maximilian P., Nout, Remi A., Chargari, Cyrus, Pieters, Bradley R., Creutzberg, Carien L., Sturdza, Alina, Lindegaard, Jacob C., van Kesteren, Zdenko, Mazeron, Renaud, Nesvacil, Nicole, Fokdal, Lars U., and Wong, David

Subjects
SURVIVAL, STATISTICS, RESEARCH, MAGNETIC resonance imaging, RETROSPECTIVE studies, DISEASES, METASTASIS, MEDICAL cooperation, VAGINAL tumors, DESCRIPTIVE statistics, RADIOISOTOPE brachytherapy, COMPUTED tomography, LONGITUDINAL method
Abstract

Simple Summary: Primary vaginal cancer is a rare disease and, consequently, evidence about the outcome of treatment is scarce. The aim of our retrospective, observational multicenter study was to assess the oncological outcome of the nowadays standing treatment for vaginal cancer, namely radio(chemo)therapy, followed by image-guided adaptive brachytherapy (IGABT). Our study confirms the results of the earlier published small monocentric IGABT studies, showing a high local control with acceptable morbidity. Notably, patients with large (T3/T4) tumors especially seem to benefit from volumetric (3D) image-guided brachytherapy, as compared to two-dimensional-based radiotherapy. In addition, although interpreted with caution, as for cervical cancer, a higher dose seems to lead to better local control. These results should, however, be further investigated in a prospective trial. Purpose: This study assessed outcomes following the nowadays standing treatment for primary vaginal cancer with radio(chemo)therapy and image-guided adaptive brachytherapy (IGABT) in a multicenter patient cohort. Methods: Patients treated with computer tomography (CT)–MRI-assisted-based IGABT were included. Retrospective data collection included patient, tumor and treatment characteristics. Late morbidity was assessed by using the CTCAE 3.0 scale. Results: Five European centers included 148 consecutive patients, with a median age of 63 years. At a median follow-up of 29 months (IQR 25–57), two- and five-year local control were 86% and 83%; disease-free survival (DFS) was 73% and 66%, and overall survival (OS) was 79% and 68%, respectively. Crude incidences of ≥ grade-three urogenital, gastro-intestinal and vaginal morbidity was 8%, 3% and 8%, respectively. Lymph node metastasis was an independent prognostic factor for disease-free survival (DFS). Univariate analysis showed improved local control in patients with T2–T4 tumors if >80 Gy EQD2α/β10 was delivered to the clinical target volume (CTV) at the time of brachytherapy. Conclusions: In this large retrospective multicenter study, IGABT for primary vaginal cancer resulted in a high local control with acceptable morbidity. These results compared favorably with two-dimensional (2D) radiograph-based brachytherapy and illustrate that IGABT plays an important role in the treatment of vaginal cancer. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results